MECHI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.566
EU - Europa 1.133
AS - Asia 556
SA - Sud America 21
AF - Africa 11
OC - Oceania 9
Totale 3.296
Nazione #
US - Stati Uniti d'America 1.561
RU - Federazione Russa 466
HK - Hong Kong 244
IT - Italia 185
PL - Polonia 172
IE - Irlanda 120
SG - Singapore 105
CN - Cina 91
SE - Svezia 68
JO - Giordania 48
IN - India 31
DE - Germania 22
FR - Francia 22
NL - Olanda 18
BR - Brasile 16
GB - Regno Unito 16
FI - Finlandia 14
SA - Arabia Saudita 12
CI - Costa d'Avorio 10
AU - Australia 9
UA - Ucraina 8
ID - Indonesia 7
BE - Belgio 6
CH - Svizzera 6
IR - Iran 5
CA - Canada 4
GR - Grecia 3
KR - Corea 3
CO - Colombia 2
HU - Ungheria 2
IL - Israele 2
TR - Turchia 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 3.296
Città #
Santa Clara 506
Hong Kong 222
Warsaw 172
Chandler 132
Dublin 120
Fairfield 120
Ashburn 79
Singapore 68
Seattle 55
Beijing 46
Woodbridge 46
Houston 45
Ann Arbor 43
Cambridge 40
Wilmington 37
Lawrence 34
Milan 34
Altamura 32
Florence 30
Princeton 27
Mumbai 26
Buffalo 22
Kent 21
Shanghai 21
Boston 19
New York 16
Moscow 14
Paris 13
Riyadh 12
Rome 11
Abidjan 10
Dearborn 10
San Diego 9
Helsinki 8
Melbourne 8
Jacksonville 7
Jakarta 7
Medford 7
Modena 7
Norwalk 7
Bern 6
Brussels 6
Frankfurt am Main 6
London 6
Los Angeles 6
West Jordan 6
Forlì 4
Genoa 4
Toronto 4
Chicago 3
Lappeenranta 3
Palermo 3
Seoul 3
Thessaloniki 3
Bologna 2
Chennai 2
Corsico 2
Dong Ket 2
Falls Church 2
Forney 2
Guangzhou 2
Hefei 2
Jinan 2
Kiryat Ono 2
Nanjing 2
Perugia 2
Pune 2
Redwood City 2
Romola 2
Salerno 2
San Giuliano Terme 2
Sopron 2
São Paulo 2
Turin 2
Yubileyny 2
Anchieta 1
Auburn Hills 1
Baku 1
Belo Horizonte 1
Berlin 1
Bielefeld 1
Boardman 1
Bratislava 1
Bremen 1
Camaçari 1
Campi Bisenzio 1
Carate Brianza 1
Chengdu 1
Colombo 1
Cotia 1
Cundinamarca 1
Dushanbe 1
Escada 1
Falkenstein 1
Friesland 1
Hanover 1
Hyderabad 1
Islington 1
Istanbul 1
Kunming 1
Totale 2.273
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 272
Suicidal ideation in a European Huntington's disease population 219
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 171
K index improves MS diagnosis and supports the differential diagnosis between MS and MS-like syndromes. 156
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis 151
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 142
Clinical and genetic characteristics of late-onset Huntington's disease 136
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 128
Human fetal striatal transplantation in disease. First italian clinic trial at the University of Florence. Preliminare Report 121
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 116
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 114
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 109
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 106
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 103
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 100
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 99
Leptomeningeal enhancement analysis in diagnostic clinical setting 93
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 92
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 91
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 91
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 87
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume 87
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 87
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 85
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 84
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 81
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 81
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 81
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg 80
Totale 3.363
Categoria #
all - tutte 10.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 0 0 0 0 0 47 29 8
2020/2021196 11 18 4 25 38 26 8 14 17 18 9 8
2021/2022176 4 15 11 10 0 10 7 21 9 9 28 52
2022/2023561 40 89 39 23 37 106 69 29 102 0 18 9
2023/2024284 11 32 31 18 22 27 13 45 4 32 30 19
2024/20251.633 62 169 113 282 384 264 24 238 77 20 0 0
Totale 3.363